Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions

American Journal of Medicine

Volumn 118, Issue 8, 2005, Pages 843-849

  Khanal, Sanjaya ^a,b   Attallah, Nizar ^b   Smith, Dean E ^c   Kline Rogers, Eva ^c   Share, David ^d   O'Donnell, Michael J ^e   Moscucci, Mauro ^c  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Blue Cross Blue Shield of Michigan Cardiovascular Consortium   (United States)

^e ST JOSEPH MERCY HOSPITAL   (United States)

Author keywords

Angioplasty; Contrast media; Contrast nephropathy; Kidney; Lipids

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

EID: 23244448755     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.03.031     Document Type: Article

References (29)

1. P. Parfrey, S. Griffiths, B. Barrett Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both a prospective controlled study N Engl J Med 320 1989 143 149
2. P. McCullough, R. Wolyn, L. Rocher, R. Levine, W. O'Neill Acute renal failure after coronary intervention incidence, risk factors, and relationship to mortality Am J Med 103 1997 368 375
3. C.S. Rihal, S.C. Textor, D.E. Grill Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
4. G. Chertow, C. Christiansen, D. Cleary Prognostic stratification in criticall ill patients with acute renal failure requiring dialysis Arch Intern Med 155 1995 1505 1511
5. R. Solomon, C. Werner, D. Mann Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 1994 1416 1420
6. M. Tepel, M. Van Der Giet, C. Schwarzfeld Prevention of radiographic contrast agent induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
7. B.J. Barrett, E.J. Carlisle Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 188 1993 171 178
8. G. Marenzi, I. Ivana Marana, G. Lauri The prevention of radiocontrast-agent-induced nephropathy by hemofiltration N Engl J Med 349 2003 1333 1340
9. M. Crisby, G. Nordin-Fredriksson, K.S. Prediman, J. Yano, J. Zhu, J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteases, and cell death in human carotid plaques Circulation 103 2001 926 933
10. S. Bellosta, N. Ferri, F. Bernini, R. Paoletti, A. Corsini Non-lipid-related effects of statins Ann Intern Med 32 2000 164 176
11. Kidney Disease Outcomes Quality Initiative (K/DOQI) Group Clinical practice guidelines for management of dyslipidemias in patients with kidney disease Am J Kidney Dis 41 suppl 3 2003 S1 S91 I-IV
12. M. Moscucci, D. Share, E. Kline-Rogers The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions J Interv Cardiol 15 2002 381 386
13. P.A. McCullough Beyond serum creatinine defining the patient with renal insufficiency and why? Rev Cardiovasc Med 4 suppl 1 2003 S2 S6S
14. R.V. Freeman, M. O'Donnell, D. Share Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose Am J Cardiol 90 2002 1068 1073
15. J. Shepherd, S.M. Cobbe, I. Ford West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
16. Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals a randomised placebo-controlled trial Lancet 360 2002 7 22
17. P.W. Serruys, P. de Feyter, C. Macaya Lescol Intervention Prevention Study (LIPS) investigators Fluvastatin for prevention of cardiac events following successful first coronary intervention a randomized controlled trial JAMA 287 2002 3215 3222
18. J. Herrmann, A. Lerman, D. Baumgart Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction Circulation 106 2002 2180 2183
19. G.L. Bakris, N. Lass, A.O. Gaber, J.D. Jones, J.C. Burnett Jr Radiocontrast medium-induced declines in renal function a role for oxygen free radicals Am J Physiol 258 1990 F115 F120
20. L.S. Weisberg, P.B. Kurnik, B.R. Kurnik Radiocontrast-induced nephropathy in humans role for vasoconstriction Kidney Int 41 1992 1408 1415
21. A.B. Dawnay, C. Thornley, I. Nockler Tamm-Horsfall glycoprotein excretion and aggregation during intravenous urography. Relevance to acute renal failure Invest Radiol 20 1985 53 57
22. B.A. Clark, D. Kim, F.H. Epstein Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans Am J Kidney Dis 30 1997 82 86
23. R.A. Zager, A.C.M. Johnson, S. Hanson Radiographic contrast media-induced tubular injury evaluation of oxidant stress and plasma membrane integrity Kidney Int 64 2003 128 139
24. F. Gueler, S. Rong, J.K. Park Postischemic acute renal failure is reduced by short-term statin treatment in a rat model J Am Soc Nephrol 13 2002 2288 2298
25. J.K. Park, D.N. Muller, E.M. Mervaala Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure-and cholesterol-lowering effects Kidney Int 58 2000 1420 1430
26. A.S. Gami, V.D. Garovic Contrast nephropathy after coronary angiography Mayo Clin Proc 79 2004 211 219
27. N.V. Guitterez, A. Diaz, G.C. Timmis Determinants of serum creatinine trajectory in acute contrast nephropathy J Interv Cardiol 15 2002 349 354
28. P.W. Serruys, P. de Feyter, C. Macaya Lescol Intervention Prevention Study (LIPS) Investigators Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention a randomized controlled trial JAMA 287 2002 3215 3222
29. V. Pasceri, G. Patti, A. Nusca Randomized trail of atorvastatin for reduction of myocardial damage during coronary intervention results of the ARMYDA Study Circulation 110 2004 674 678